• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Few Americans attain CV health goals associated with decreased mortality

News
Article

A recent study from JAMA indicates that most Americans aren't meeting the necessary goals to lower CV risks.

Meeting a greater number of guideline-specified cardiovascular (CV) health goals was associated with a lower risk of total and CV mortality. Unfortunately, the proportion of Americans meeting these goals is low, according to a recent study published online in JAMA.

CV disease is the leading cause of death in the United States, accounting for about 1 in every 3 deaths annually, and resulting in estimated overall costs of $444 billion.

They found that only 1.2% of Americans sampled from the NHANES 2005-2010 data set met all 7 of the above health goals. Moreover, this number was down from 2.0% in the 1988-1994 cohort.

The prevalence of current smoking declined from 27.9% to 22.6% from the 1988-1994 to the 2005-2010 cohort, but the prevalence of adults with desirable total cholesterol levels (<200 mg/dL) and blood pressure (<120 mm Hg/<80 mm Hg) was unchanged, and the prevalence of consuming a healthy diet, having a BMI<25, and having a fasting blood glucose <100 mg/dL declined (worsened) significantly.

"The lack of improvement, and in some cases worsening, is very concerning given that mortality rates are inversely related to the number of the 7 criteria met," noted Formulary board member Craig I. Coleman, PharmD, associate professor of pharmacy, University of Connecticut, Storrs, Conn.

Adjusted hazard ratios were 0.49 (95% CI, 0.33–0.74; P<.001) for all-cause mortality, 0.24 (95% CI, 0.13–0.47; P<.001) for CVD mortality, and 0.30 (95% CI, 0.13–0.68; P<.001) for ischemic heart disease mortality for Americans who met 6 or more of the health goals compared to 1 or fewer.

Dr Coleman said, "As healthcare professionals . . . we need to further emphasize the importance of lifestyle modification to our patients and optimize their pharmacotherapy."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.